Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of romiplostim in the treatment of
thrombocytopenia in pediatric patients with Immune thrombocytopenia purpura (ITP) as measured
by durable platelet response.